
|Articles|October 16, 2012
FDA: Continuing meningitis investigation reveals other NECC injectables are now questionable
Another drug could be contaminated and may be the cause of a meningitis case, the FDA says.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
2
CMS Announces 15 New High-Cost Drugs for Medicare Price Negotiation Program
3
Q&A: Pharmacists Combat Vaccine Fatigue by Personalizing Recommendations for Older Adults
4
How Oral GLP-1 Medication Will Impact the Patient Medication Journey
5


















